Sassun-Mayo N/tumor, lymph node, and metastasis staging provided superior overall survival stratification vs the current @AJCCancer staging, suggesting that their implementation could improve prognostication in colon cancer.

Neoadjuvant immunotherapy versus adjuvant chemotherapy in anorectal melanoma ➡️ Kaplan–Meier analysis of the local surgery cohort revealed that the 3-year overall survival was comparable with neoadjuvant immunotherapy (65%) and adjuvant chemotherapy (45%) (P = 0.179) Conversely, in the radical surgery group neoadjuvant immunotherapy substantially increased 3-year overall survival (75% versus 8.3%, HR = 0.16, 95% c.i.: 0.04 to 0.58, P = 0.002) This finding uniquely suggests that a strategy of neoadjuvant immunotherapy plus radical surgery could significantly improve the 3-year overall survival Work by Richard Sassun, Annaclara Sileo, Jyi Cheng Ng, Tommaso Violante, Ibrahim A Gomaa, Matthew S Block, William R G Perry, Nicholas P McKenna, Kristen K Rumer, David W Larson #SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology #Some4COLoprocto

This year’s first place award for the CoC Paper Competition is awarded to Richard Sassun, MD from Mayo Clinic Rochester. Dr. Sassun received his award at this year’s CoC Plenary Session in San Francisco on 10/19. Congratulations!